This protocol addresses cytomegalovirus (CMV) retinitis in the specific setting of retinal detachment secondary to CMV retinitis — a vision-threatening complication that calls for a distinct surgical strategy beyond systemic management alone.
Retinal detachment is a recognised complication of CMV retinitis. Vitrectomy is the established surgical intervention for this scenario. The primary clinical goal is retinal reattachment, and outcomes are monitored over several months postoperatively.
The intervention involves a vitreoretinal surgical procedure. The complete regimen — including all procedural details, decision points, and follow-up considerations — is available in the full structured protocol below.
DOI: 10.3390/v16091427
In addition to antiviral therapy and immunotherapy, vitrectomy is the standard treatment of retinal detachment secondary to CMVR with 56–94% silicone oil repair effectiveness in HIV patients.
While the retinal attachment rate was 87.2% at 1 month and 82.1% at 3 months postoperatively, it decreased to 71.8% at 6 months.
View source ↗